- Title
- Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation
- Creators - without role
- Lucie M. Turcotte - University of MinnesotaTao Wang - Medical College of WisconsinMichael T. Hemmer - Medical College of WisconsinStephen R. Spellman - National Marrow Donor ProgramMukta Arora - University of Minnesota Medical CenterDaniel Couriel - Utah Blood & Marrow Transplant Program, Salt Lake City, UT USAAmin Alousi - The University of Texas MD Anderson Cancer CenterJoseph Pidala - Moffitt Cancer CenterHisham Abdel-Azim - Children's Hospital of Los AngelesIbrahim Ahmed - Children's Mercy HospitalAmer Beitinjaneh - University of MiamiDavid Buchbinder - Children's Hospital of Orange CountyMichael Byrne - Vanderbilt University Medical CenterNatalie Callander - UW Health University HospitalNelson Chao - Duke Medical CenterSung Wong Choi - University of Michigan–Ann ArborZachariah DeFilipp - Massachusetts General HospitalShahinaz M. Gadalla - Cancer GeneticsRobert Peter Gale - Imperial College LondonUsama Gergis - New York Hospital QueensShahrukh Hashmi - King Faisal Specialist Hospital & Research CentrePeiman Hematti - UW Health University HospitalLeona Holmberg - Fred Hutch Cancer CenterYoshihiro Inamoto - STEMRammurti T. Kamble - Baylor College of MedicineLeslie Lehmann - Dana-Farber Cancer InstituteMargaret A. MacMillan - University of MinnesotaZachariah McIver - Atrium Health Wake Forest BaptistTaiga Nishihori - Moffitt Cancer CenterMaxim Norkin - Florida CollegeTracey O'Brien - Sydney Children's HospitalRichard F. Olsson - Karolinska InstitutetRan Reshef - Columbia University Irving Medical CenterAyman Saad - University of Alabama at BirminghamBipin N. Savani - Vanderbilt University Medical CenterHarry C. Schouten - Acad Ziekenhuis, Dept Hematol, Maastricht, NetherlandsSachiko Seo - National Cancer Center Hospital EastMelhem Solh - Northside HospitalLeo Verdonck - IsalaRavi Vij - Washington University in St. LouisBaldeep Wirk - Seattle Cancer Care AllianceJean Yared - University of Maryland, BaltimoreMary M. Horowitz - Medical College of WisconsinJennifer M. Knight - Medical College of WisconsinMichael R. Verneris - University of Colorado Denver
- Publication Details
- Bone marrow transplantation (Basingstoke), Vol.53(7), pp.932-937
- Publisher
- Springer Nature
- Number of pages
- 6
- Grant note
- Medac, GmbH Children's Cancer Research Fund, Minneapolis, MN Sanofi Genzyme; Sanofi-Aventis; Genzyme Corporation Juno Therapeutics 5U24CA076518 / Public Health Service Grant from the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) Jazz Pharmaceuticals, Inc.; Jazz Pharmaceuticals Seattle Genetics Mesoblast Sunesis Pharmaceuticals, Inc. Kite Pharma, Inc. Shire Spectrum Pharmaceuticals, Inc. Karyopharm Therapeutics, Inc. UL1TR001436; KL2TR001438 / National Center for Advancing Translational Sciences (National Institutes of Health (NIH)) Millennium, the Takeda Oncology Co. Miltenyi Biotec, Inc. National Institute of Allergy and Infectious Diseases (NIAID); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID) Fred Hutchinson Cancer Research Center KL2TR001438 / NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS) PIRCHE AG Cerus Corporation N00014-17-1-2388; N0014-17-1-2850 / Office of Naval Research St. Baldrick's Foundation Amgen, Inc.; Amgen Mediware Pharmacyclics, LLC Atara Biotherapeutics, Inc. National Marrow Donor Program Novartis Pharmaceuticals Corporation; Novartis Medical College of Wisconsin; General Electric University of Minnesota; University of Minnesota System Takeda Oncology; Takeda Pharmaceutical Company Ltd PCORI; Patient-Centered Outcomes Research Institute - PCORI U10HL069294 / NATIONAL HEART, LUNG, AND BLOOD INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI) Gamida Cell Ltd. Otsuka Pharmaceutical Co, Ltd.-Japan; Otsuka Pharmaceutical Merck Co, Inc.; Merck & Company MesoScale Diagnostics, Inc. Pfizer, Inc; Pfizer Swedish Orphan Biovitrum, Inc. HistoGenetics, Inc. Telomere Diagnostics, Inc. Chimerix, Inc. Immucor Angiocrine Bioscience, Inc. Incyte Corporation Celgene Corporation; Bristol-Myers Squibb Bristol Myers Squibb Oncology; Bristol-Myers Squibb Astellas Pharma US; Astellas Pharmaceuticals Be the Match Foundation ZIACP010190 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) MedImmune; AstraZeneca; Medimmune NCI; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) HHSH250201200016C / Health Resources and Services Administration (HRSA/DHHS); United States Department of Health & Human Services; United States Health Resources & Service Administration (HRSA) Amneal Biosciences 4U10HL069294 / NHLBI; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI) Gilead Sciences, Inc.; Gilead Sciences Janssen Scientific Affairs, LLC Actinium Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Ltd Neovii Biotech NA, Inc. bluebird bio, Inc.
- Identifiers
- 9948524308331
- Academic Unit
- King Saud University
- Language
- English
- Resource Type
- Journal article
Journal article
Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation
Bone marrow transplantation (Basingstoke), Vol.53(7), pp.932-937
01/07/2018
PMCID: PMC6041147
PMID: 29382954
Metrics
1 Record Views